Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Respiratory Oxygen Delivery Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 4623| Published Date: Jan-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Respiratory Oxygen Delivery Devices Market size was valued at USD 15.33 Billion in 2025 and is anticipated to grow at a 8% CAGR from 2026 to 2035, crossing USD 33.1 Billion by 2035. The industry revenue for 2026 is calculated at USD 16.41 billion.

Base Year Value (2025)
USD 15.33 Billion
CAGR (2026-2035)
8%
Forecast Year Value (2035)
USD 33.1 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Respiratory Oxygen Delivery Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads due to established oxygen therapy infrastructure, mature reimbursement systems, and consistent device utilization across hospitals, homecare, and long-term care settings.
  • Asia Pacific is projected to grow at a 9.04% CAGR, supported by expanding healthcare networks, respiratory care capacity, and demand for cost-effective oxygen solutions.

Segment Momentum

  • Hospitals held a 54.35% share in 2025 due to continuous demand for oxygen therapy across emergency departments, intensive care units, inpatient care, and post-operative respiratory support settings.
  • Venturi masks are the fastest-growing product segment because they enable more precise oxygen concentration delivery, making them increasingly preferred for patients requiring carefully controlled respiratory support.

Market Expansion Drivers

  • Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally.
  • Expanding elderly population driving long-term adoption of respiratory support technologies.
  • Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent players in the respiratory oxygen delivery devices market include Koninklijke Philips N.V. (Netherlands), ResMed Inc. (United States), Medtronic plc (Ireland), Masimo Corporation (United States), Chart Industries, Inc. (United States), Invacare Corporation (United States), Drive DeVilbiss Healthcare (United States), Air Liquide S.A. (France), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Smiths Medical (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally

The rising burden of chronic and acute respiratory conditions is steadily driving demand for the respiratory oxygen delivery devices market, as COPD and asthma patients often require recurring oxygen support during exacerbations while RSV continues to increase the need for short-duration respiratory intervention in vulnerable populations. This shifts procurement patterns across hospitals, emergency departments, ambulatory settings, and home care providers toward a broader mix of oxygen concentrators, cylinders, masks, cannulas, and related delivery interfaces. In practice, higher case volumes lead clinicians and care systems to prioritize reliable oxygen access, faster device turnover, and wider placement of respiratory support equipment, strengthening market development through both replacement demand and the expansion of installed device bases.

Expanding elderly population driving long-term adoption of respiratory support technologies

An aging population is reinforcing market demand for the respiratory oxygen delivery devices market because older adults are more likely to experience chronic lung disease, reduced pulmonary function, post-infection complications, and multimorbidity that make oxygen supplementation part of long-term disease management rather than episodic treatment. This changes purchasing behavior toward durable, easy-to-operate systems suited for continuous or intermittent use in home care, rehabilitation, long-term care, and assisted living environments. As providers and caregivers look for devices that can support adherence, safety, and lower-intensity monitoring outside acute settings, the market sees stronger penetration of respiratory support technologies designed for extended use and routine patient management.

Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption

The shift toward portable home-based care is influencing market adoption in the respiratory oxygen delivery devices market by moving oxygen therapy away from fixed, facility-centered delivery models and into outpatient and home settings where mobility, convenience, and independence directly affect treatment acceptance. Portable concentrators fit this transition by reducing reliance on repeated clinic visits and cumbersome refill logistics, which makes physicians more willing to prescribe oxygen support earlier for appropriate patients and encourages providers to structure care pathways around discharge-to-home respiratory management. That practical alignment with outpatient care is contributing to market size growth through rising demand for compact, user-friendly devices that support longer use outside hospitals without disrupting daily activity.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of COPD, asthma, and RSV increasing oxygen therapy demand globally 2.00% Moderate North America, Asia Pacific High Near Term
Expanding elderly population driving long-term adoption of respiratory support technologies 1.70% Moderate Asia Pacific, Europe High Mid Term
Growing preference for portable home-based oxygen concentrators accelerating outpatient respiratory care adoption 1.50% Low North America, Asia Pacific Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
XX% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest regional market share in 2025 for the respiratory oxygen delivery devices market, bolstered by established hospital and homecare oxygen therapy infrastructure, broad clinical familiarity with oxygen delivery systems, and consistent device utilization across acute and chronic respiratory care. Demand in the region is strengthened by the routine management of COPD, sleep-related breathing disorders, and post-acute respiratory complications, which keeps procurement active across hospitals, long-term care settings, and home healthcare channels. Leadership is also sustained by the region’s mature reimbursement environment and stronger access to portable and stationary oxygen equipment, enabling faster device replacement cycles and wider patient adoption in day-to-day treatment pathways.

Asia Pacific is projected to expand at a 9.04% CAGR over the forecast period, with growth in the respiratory oxygen delivery devices market accelerating as healthcare systems broaden access to respiratory support and providers increase capacity for treating rising volumes of chronic and acute respiratory cases. Adoption is gaining momentum through expanding hospital networks, improving availability of oxygen therapy in secondary and tertiary care settings, and greater use of home-based respiratory support as care delivery shifts beyond major urban centers. The region’s growth is also being fueled by practical demand for cost-effective oxygen delivery solutions that can serve large patient populations across diverse care environments.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Clinical Care Optimization

Germany is emphasizing respiratory oxygen delivery devices that support efficient hospital care and expanding home healthcare services. The country prioritizes reliable oxygen delivery technologies that improve patient comfort while meeting stringent clinical performance requirements.

France 🇫🇷

Patient-Centered Oxygen Care

France is strengthening the respiratory oxygen delivery devices market through broader adoption of home oxygen therapy and improved chronic respiratory care. Healthcare providers in France focus on reliable, comfortable devices that simplify long-term patient management and clinical follow-up.

Italy 🇮🇹

Community Care Integration

Italy is expanding the use of respiratory oxygen delivery devices to support community-based care for patients with chronic respiratory conditions. The country prioritizes practical oxygen therapy systems that improve accessibility, ease of use, and continuity of care beyond hospital settings.

Japan 🇯🇵

Portable Therapy Solutions

Japan continues adopting compact respiratory oxygen delivery devices that align with home healthcare expansion and long-term respiratory disease management. Healthcare providers in Japan focus on dependable, easy-to-use systems that support patient mobility and continuous treatment.

South Korea 🇰🇷

Connected Respiratory Support

South Korea is integrating respiratory oxygen delivery devices with digital healthcare initiatives and advanced patient monitoring systems. The country emphasizes portable equipment and connected respiratory solutions that improve treatment management across hospitals and home care environments.

United States 🇺🇸

Home Respiratory Care

The U.S. respiratory oxygen delivery devices market is supported by growing demand for home-based respiratory management and long-term oxygen therapy. Healthcare providers in the U.S. prioritize portable, connected, and patient-friendly devices that improve treatment adherence across care settings.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Respiratory Oxygen Delivery Devices Market Share (%), End-use, 2025

Hospitals
Home Care
Outpatient Facilities

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

Hospitals accounted for a 54.35% share of the respiratory oxygen delivery devices market in 2025, reflecting their central role in managing acute respiratory distress, post-operative oxygen support, and emergency care. Their leadership is maintained through the continuous need for oxygen delivery across intensive care units, emergency departments, and inpatient settings where clinical staff require dependable access to a broad range of oxygen administration devices. The same care environment is also driving ongoing growth, as hospitals remain the primary setting for treating severe respiratory cases and monitoring patients who need controlled, uninterrupted oxygen therapy, keeping demand elevated within the respiratory oxygen delivery devices market.

Product Segment Analysis: Oxygen Masks (Largest Segment) vs Venturi Masks (Fastest-Growing Segment)

With a 38.12% share in 2025, oxygen masks led the respiratory oxygen delivery devices market because they are widely used across routine oxygen therapy settings and fit a broad range of patient needs in hospitals and other clinical environments. Their market leadership is underpinned by practical ease of use, broad availability, and suitability for general oxygen administration, making them a standard choice when rapid and straightforward respiratory support is required.

Venturi masks are emerging as the fastest-growing product segment in the respiratory oxygen delivery devices market due to their role in delivering more controlled oxygen concentrations than conventional alternatives. Growth is being underpinned by clinical situations where precision in oxygen delivery is important, particularly for patients who require carefully managed respiratory support rather than variable oxygen flow. This makes Venturi masks increasingly relevant in care settings that prioritize tighter oxygen administration control.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Hospitals, Outpatient Facilities, Home Care Hospitals Hospitals
Product Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others Oxygen Masks Venturi Masks
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the respiratory oxygen delivery devices market:

1. Koninklijke Philips N.V. (Netherlands)

2. ResMed Inc. (United States)

3. Medtronic plc (Ireland)

4. Masimo Corporation (United States)

5. Chart Industries Inc. (United States)

6. Invacare Corporation (United States)

7. Drive DeVilbiss Healthcare (United States)

8. Air Liquide S.A. (France)

9. Fisher & Paykel Healthcare Corporation Limited (New Zealand)

10. Smiths Medical (United States)

The respiratory oxygen delivery devices market is experiencing growth through the introduction of portable and digitally connected respiratory support systems. Manufacturers are focusing on improving patient comfort, monitoring accuracy, and homecare compatibility across oxygen therapy solutions. Advancements in telehealth integration and lightweight device design are also strengthening market differentiation.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Respiratory Oxygen Delivery Devices Market — Custom Segments

Segment Sub-Segment
No segment data available.

Respiratory Oxygen Delivery Devices Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the respiratory oxygen delivery devices market?

In 2026 the market for respiratory oxygen delivery devices is worth approximately USD 16.41 billion.

How is the respiratory oxygen delivery devices industry projected to perform over the next decade?

Respiratory Oxygen Delivery Devices Market size is set to grow from USD 15.33 billion in 2025 to USD 33.1 billion by 2035 reflecting a CAGR greater than 8% through 2026-2035.

How is the growing burden of respiratory diseases influencing purchasing trends in the respiratory oxygen delivery devices market?

Increasing cases of COPD, asthma, and RSV are expanding procurement across hospitals, emergency care, ambulatory settings, and home healthcare providers for oxygen delivery systems that support reliable respiratory care.

Why are portable oxygen concentrators driving outpatient adoption in the respiratory oxygen delivery devices market?

Portable concentrators support home-based respiratory management by improving mobility, reducing dependence on facility-based care, and enabling physicians to transition suitable patients to outpatient oxygen therapy earlier.

Why are hospitals the largest end-use segment in the respiratory oxygen delivery devices market?

Hospitals held a 54.35% share in 2025 due to continuous demand for oxygen therapy across emergency departments, intensive care units, inpatient care, and post-operative respiratory support settings.

Which product segment is growing fastest in the respiratory oxygen delivery devices market?

Venturi masks are the fastest-growing product segment because they enable more precise oxygen concentration delivery, making them increasingly preferred for patients requiring carefully controlled respiratory support.

Why is North America the leading region for respiratory oxygen delivery devices?

North America leads due to established oxygen therapy infrastructure, mature reimbursement systems, and consistent device utilization across hospitals, homecare, and long-term care settings.

How is Asia Pacific accelerating growth in oxygen delivery devices?

Asia Pacific is projected to grow at a 9.04% CAGR, supported by expanding healthcare networks, respiratory care capacity, and demand for cost-effective oxygen solutions.

Who are the major participants shaping the respiratory oxygen delivery devices landscape?

Prominent players in the respiratory oxygen delivery devices market include Koninklijke Philips N.V. (Netherlands), ResMed Inc. (United States), Medtronic plc (Ireland), Masimo Corporation (United States), Chart Industries, Inc. (United States), Invacare Corporation (United States), Drive DeVilbiss Healthcare (United States), Air Liquide S.A. (France), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Smiths Medical (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →